Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Space Act Agreement Stories

2013-08-19 23:03:56

Last week, NASA announced that it has added additional milestones to Sierra Nevada Corporation’s (SNC) Dream Chaser® Space Act Agreement (SAA) under the Commercial Crew Integrated Capability (CCiCap) initiative. Sparks, NV (PRWEB) August 19, 2013 Last week, NASA announced that it has added additional milestones to Sierra Nevada Corporation's(SNC) Dream Chaser® Space Act Agreement (SAA) under the Commercial Crew Integrated Capability (CCiCap) initiative. NASA amended...

Dream Chaser Ground Tests
2013-08-15 10:17:38

Brett Smith for redOrbit.com - Your Universe Online The Dream Chaser spacecraft is progressing as expected through ground tests at a California facility, NASA announced this week. Developed by the Sierra Nevada Corporation (SNC), Dream Chaser is described as a spaceplane capable of flying at sub-orbital and orbital altitudes. The space agency has plans to use the craft for sending personnel and supplies to and from the International Space Station. Earlier this month, the Dream Chaser...

2013-06-05 16:20:48

HOUSTON, June 5, 2013 /PRNewswire-USNewswire/ -- A new fiber-optic monitoring system developed through a Space Act Agreement between NASA and Astro Technology Inc. of Houston is helping to increase safety for workers and reduce the risk of leaks and spills on two oil platforms off the coast of West Africa. The technology also has potential future space exploration applications. (Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO ) Known as the Tendon Tension Monitoring System...

2012-10-12 11:20:23

HOUSTON, Oct. 12, 2012 /PRNewswire-USNewswire/ -- NASA's Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness. (Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO) Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result,...

2012-10-12 07:20:04

IRVINE, Calif. , Oct. 12, 2012 /PRNewswire/ -- Epiomed Therapeutics, Inc. ("Epiomed") announced today that it has entered into a Reimbursable Space Act Agreement (SAA) with the National Aeronautics and Space Administration (NASA) Lyndon B. Johnson Space Center in Houston, Texas for the development, distribution, manufacture and market release of INSCOP, an intra-nasal scopolamine product. A gel formulation of INSCOP has previously been developed and tested under a SAA between NASA-Johnson...

2012-09-14 06:44:51

NASA is announcing opportunities for academia, industry and government agencies to develop and carry out research and technology demonstrations on the International Space Station using the newly installed Space Communications and Navigation (SCAN) testbed. There are two announcements of opportunity. The SCAN Testbed Experiment Opportunity invites industry and other government agencies to enter into Space Act Agreements with NASA to use the space station's SCAN platform. The SCAN Testbed...